Parnian Zia‐Amirhosseini

Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys

Timothy K. Hart, Richard M. Cook, Parnian Zia‐Amirhosseini et al. · Journal of Allergy and Clinical Immunology · 2001 · 241 citations · Full text

Medicine, Immunology, Pharmacology +16

Preclinical efficacy and safety of pascolizumab (SB 240683): a humanized anti-interleukin-4 antibody with therapeutic potential in asthma

T K Hart, M N Blackburn, Michael Brigham‐Burke et al. · Clinical & Experimental Immunology · 2002 · 202 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Reactivity of tolmetin glucuronide with human serum albumin. Identification of binding sites and mechanisms of reaction by tandem mass spectrometry.

A Ding, Parnian Zia‐Amirhosseini, A. F. McDonagh et al. · Drug Metabolism and Disposition · 1995 · 89 citations

Life Sciences, Biochemistry, Pharmacology +17

Pharmacokinetics and Pharmacodynamics of SB-240563, a Humanized Monoclonal Antibody Directed to Human Interleukin-5, in Monkeys

Parnian Zia‐Amirhosseini, Elisabeth A. Minthorn, Lisa J. Benincosa et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 77 citations

Pharmacy, Pharmacokinetics, Pharmacology +9

Stereoselective binding properties of naproxen glucuronide diastereomers to proteins

A Bischer, Parnian Zia‐Amirhosseini, Masahiro Iwaki et al. · Journal of Pharmacokinetics and Biopharmaceutics · 1995 · 38 citations

Pharmacy, Medicinal Chemistry, Pharmacology +8